| 
·        
  Parkinsonism: 
·        
  Parkinsonism is a
  neurodegenerative disorder 
·        
  Loss of  neuron in basal ganglia (SNPC)  that affect movement control (motor
  functions) 
·        
  Degeneration of Dopaminergic
  neurons in Substantia Nigra Pars Compacta (SNPC) 
·        
  Decrease in level of Dopamine. 
·        
  Imbalance of Dopamine
  (inhibitory) and acetylcholine (Excitatory) in Straitum part. 
·        
  Symptoms: Bradykinesia,
  tremors, mask like face, abnormal gait and posture, rigidity,
  hypersalivation. | ||||||||||
| 
N-methy-4-phenyl tetrahydropyridine
  (MPTP) toxin induce parkinsonism | ||||||||||
| 
Classification | ||||||||||
| 
Drugs altering dopaminergic system | 
Drugs altering cholinergic system | |||||||||
| 
1.       COMT inhibitor 
·        
  Peripheral COMT inhibitor-Entacapone 
·        
  Peripheral and central COMT inhibitor-Tolcapone 
2.      
  Dopaminergic agonist- 
·        
  Ergot derivative-                                                                     
  Bromocriptine, Pergolide 
·        
  Non ergot derivative-Apomorphine,
  Pramipexole, Ropinirole, Rotigotine 
3.      
  Dopamine precursor- Levodopa 
4.      
  Nmda receptor antagonist- Amantadine 
5.      
  Peripheral decarboxylase inhibitors-Benserazide,
  Carbidopa 
6.      
  Selective MAO-B inhibitor-Selegeline, Rasagiline | 
1.      
  Central anticholinergics- Benzhexol,
  Biperiden, Procyclidine, Benztropin 
2.      
  Antihistaminics- Orphenadrine, Promethazine | |||||||||
| 
Levodopa | 
·        
  Dopamine is hydrophilic in
  nature so not cross BBB- that’s why we use prodrug levodopa (lipophilic) 
·        
  Peripherally levodopa is
  metabolised by dopa decarboxylase, therefore only 4-5% levodopa reach in
  brain 
·        
  To decrease peripheral
  metabolism: levodopa always used in combination with dopa decarboxylase inhibitors
  (Carbidopa, Benserazide) 
·        
  Levodopa cause adverse
  effects like postural hypotension, nausea, vomiting, arrythmia, psychosis
  (hallucination), dyskinesia 
·        
  Adverse effect of Levodopa
  like postural hypotension, nausea, vomiting, arrythmia are decreased by Carbidopa
  (by inhibiting peripheral conversion) but dyskinesia, psychosis not cured. 
·        
  Pyridoxine (vitamin b6)
  decrease effectiveness of Levodopa 
·        
  Brown discolouration of urine
  and saliva | |||||||||
| 
 | 
                               COMT 
·        
  Entcapone (short acting)
  inhibit COMT enzyme peripherally only. 
·        
  Tolcapone (long acting)
  inhibit COMT enzyme both peripherally as well as centrally 
·        
  Tolcapone cause
  hepatotoxicity  
·        
  COMT inhibitors cause
  diarrhoea and orange red discolouration of urine. | |||||||||
| 
Selective MAO-B inhibitors  | 
·        
  These are the irreversible inhibitor of MAO-B 
·        
  At low dose they only inhibit
  MAO-B, but at high dose they also inhibit MAO-A, so there is chances of
  cheese reaction and serotonin syndrome with TCA antidepressants. 
·        
  They have some
  neuroprotective effect (decrease neurodegeneration) | |||||||||
| 
Dopamine agonist | 
 | |||||||||
| 
NMDA receptor antagonist | 
·        
  Inhibit glutamate activity by
  blocking NMDA receptor 
·        
  Increase dopamine release as
  well 
·        
  Also have anticholinergic
  property 
·        
  It is an antiviral agent (for
  influenza) 
·        
  Cause ankle edema and livedo reticularis
  (bluish discolouration) | |||||||||
| 
Drugs altering central cholinergic level | 
·        
  These are the 1st
  choice of drug in drug induced parkinsonism promethazine and orphenadrine are
  1st generation antihistaminic drugs which have high
  anticholinergic property. 
·        
  Affect memory, cause urinary
  retention, blurred vision. | |||||||||
| 
\ | ||||||||||
Saturday, 4 February 2017
Anti Parkinsonian Drugs
Labels:
Parkinsonism
Subscribe to:
Post Comments (Atom)
 
No comments:
Post a Comment